P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969636.32603.d4 |
| _version_ | 1797280793834291200 |
|---|---|
| author | Fabian Lang Susan Branford Joseph P. Lyssikatos Helen Collins Andreas Hochhaus |
| author_facet | Fabian Lang Susan Branford Joseph P. Lyssikatos Helen Collins Andreas Hochhaus |
| author_sort | Fabian Lang |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:46:19Z |
| format | Article |
| id | doaj.art-81c89a7a816d4d9688512d7264ac3a7a |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:46:19Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-81c89a7a816d4d9688512d7264ac3a7a2024-03-03T06:25:18ZengWileyHemaSphere2572-92412023-08-017e32603d410.1097/01.HS9.0000969636.32603.d4202308003-00583P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIESFabian Lang0Susan Branford1Joseph P. Lyssikatos2Helen Collins3Andreas Hochhaus41 Klinikum der Goethe Universitat, Frankfurt, Germany2 Royal Adelaide Hospital3 Enliven Therapeutics, Boulder, United States3 Enliven Therapeutics, Boulder, United States4 Universitaetsklinikum Jenahttp://journals.lww.com/10.1097/01.HS9.0000969636.32603.d4 |
| spellingShingle | Fabian Lang Susan Branford Joseph P. Lyssikatos Helen Collins Andreas Hochhaus P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES HemaSphere |
| title | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_full | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_fullStr | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_full_unstemmed | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_short | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_sort | p683 trials in progress first in human study of elvn 001 a selective bcr abl1 tyrosine kinase inhibitor in patients with chronic myeloid leukemia who failed previous tyrosine kinase inhibitor therapies |
| url | http://journals.lww.com/10.1097/01.HS9.0000969636.32603.d4 |
| work_keys_str_mv | AT fabianlang p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT susanbranford p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT josephplyssikatos p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT helencollins p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT andreashochhaus p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies |